Polyrizon Ltd. (PLRZ)
PLRZ Stock Price Chart
Explore Polyrizon Ltd. interactive price chart. Choose custom timeframes to analyze PLRZ price movements and trends.
PLRZ Company Profile
Discover essential business fundamentals and corporate details for Polyrizon Ltd. (PLRZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
29 Oct 2024
Employees
2.00
CEO
Tomer Izraeli
Description
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.
PLRZ Financial Timeline
Browse a chronological timeline of Polyrizon Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Stock split effective on 27 May 2025
Shares were split 1 : 250 , changing the number of shares outstanding and the price per share accordingly.
PLRZ Stock Performance
Access detailed PLRZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.